Full Press Release Details
Organigram Announces May 21st as
Inaugural Date of Trading
on the Nasdaq Global Select Market
MONCTON, May 17, 2019/CNW/ Organigram Holdings Inc. (TSX
VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the
"Company" or "Organigram"), a leading licensed producer of cannabis, is pleased
to announce that its common shares will commence trading on the Nasdaq Global
Select Market under the symbol "OGI" on Tuesday May 21, 2019. Organigram s
common shares will continue to be listed and trade on the Toronto Venture
Exchange (TSXV), also under the symbol "OGI". The Company's common shares
will continue to trade on the OTCQX under the symbol "OGRMF" until market close
In conjunction with this Nasdaq listing, Organigram s common
shares will become DWAC/FAST eligible for U.S. shareholders.
"We are pleased to celebrate this significant company
milestone," says Greg Engel, CEO, Organigram. "We are proud to have assembled a
world-class team and facility that continues to deliver value to our
shareholders. This listing will help us continue to demonstrate our commitment
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a licensed producer
of cannabis and cannabis-derived products in Canada.
Organigram is focused on producing the highest-quality,
indoor-grown cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend the
Company's global footprint. Organigram has also developed a portfolio of legal
adult use recreational cannabis brands including The Edison Cannabis Company,
Ankr Organics, Trailer Park Buds and Trailblazer. Organigram's primary facility
is located in Moncton, New Brunswick and the Company is regulated by the
Cannabis Act and the Cannabis Regulations (Canada).
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by the use of
words such as "plans", "expects", "estimates", "intends", "anticipates",
"believes" or variations of such words and phrases or state that certain
actions, events, or results "may", "could", "would", "might" or "will" be taken,
occur or be achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual results, events,
performance or achievements of Organigram to differ materially from current
expectations or future results, performance or achievements expressed or implied
by the forward-looking information contained in this news release. Examples of
such statements include statements with respect to its inaugural trading date.
Risks, uncertainties and other factors involved with forward-looking information
could cause actual events, results, performance, prospects and opportunities to
differ materially from those expressed or implied by such forward-looking
information, including risks associated with timing and regulatory approvals and
such risks as disclosed in the Company s most recent annual information form and
other Company's documents filed from time to time on SEDAR (see www.sedar.com).
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release. Although the
Company believes that the assumptions and factors used in preparing the forward-looking
information in this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking information
included in this news release are made as of the date of this news release and
the Company disclaims any intention or obligation, except to the extent required
by law, to update or revise any forward-looking information, whether as a result
of new information, future events or otherwise. We seek safe harbor.
| For Investor Relations enquiries, please contact: |
| Amy Schwalm |
| Vice President, Investor Relations |
| Amy.Schwalm@organigram.ca |
| (416) 704-9057 |
| For Media enquiries, please contact: |
| Ray Gracewood |
| Senior Vice President, Marketing and Communications |
| rgracewood@organigram.ca |
| (506) 645-1653 |